Sunday, November 30, 2014

Transplant Policies Change, Life Goes on with PKD

Kidney Transplant Policies

From Cleveland.com, By Angela Townsend, The Plain Dealer


TBA - new kidney donation wait list rules to help people on dialysis


Changes to the way the national kidney transplant wait list is administered will take effect next week, a move that will benefit people who typically wait longer than others for a new kidney.

Michael Brown of Euclid, who has been on dialysis since he was 20, said he'll be ready for a transplant when the call finally comes.

"The average wait for someone in Ohio is something like five years," said Brown, 31. He's been on the transplant wait list for three years.

Still, he said, "You never know. You never really know what's going to come available when."

On Dec. 4, the United Network for Organ Sharing, which maintains the country's transplant database, will enact new kidney transplant policies.

One of the criteria for matching someone on the wait list for a donor kidney is the length of time they have been on the list. For people who began dialysis before being added to the list, the new policy now calculates the waiting time from the date dialysis started.

Children who need a kidney transplant will remain at the top of the list because they face growth and developmental issues the longer they have to wait.

Brown is among the nearly 102,000 people in the U.S. - including more than 2,500 in Ohio - currently on the kidney wait list. When he was 20, he started dialysis after his kidney function – which had begun to decline when he was around 12 years old – dropped to 10 percent of normal function.

But as physically and mentally draining that dialysis is - three times a week, four-and-a-half hours at a time - Brown didn't explore the option of a kidney transplant right away.

Part of the delay, he said, was being told by physicians at another hospital that he was too heavy for transplant surgery.

Brown also said he has never been comfortable asking a friend of relative to donate a kidney to him.

Fear was another factor in his not pursuing a transplant.

"I've never had surgery before," he said. "Someone's organ being taken out of their body and put in your body, that's a jarring situation."

Over the years, Brown has lost about 30 pounds from his 6-foot-1 frame. And after changing physicians for his kidney care, and hearing about the benefits of transplant surgery, he began to look at things differently.

Three years ago, the transplant team at University Hospitals Case Medical Center – which performs a couple of kidney transplants each week - placed Brown on the kidney wait list. His wait, doctors told him, would be at least five years.

With the policy changes, Brown's credited wait time will be recalculated from three years to 11 years.

It's impossible to pinpoint how the alterations to the kidney allocation system will impact the wait time for a specific person, said Dr. Mark Aeder, a member of UH's transplant team and vice chair of the committee that developed the new policy.

For a small number of people currently on the list, several years of waiting will be shaved off immediately, he said.

For the vast majority, where they live and what their blood type is will continue to be a factor in how long they will wait.

"There are some areas of the country where people wait for 10 years, while in other parts the wait is a year and a half," he said.  [Read more]



From Nephrology News

US policy that gives priority to prior organ donors who need a transplant is working

Prior organ donors who later need a kidney transplant experience brief waiting times and receive excellent quality kidneys, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings indicate that a U.S. policy that gives priority to prior organ donors on the transplant waiting list is working, according to the researchers.

Live organ donors provide a remarkable gift to relieve another person of the burden of organ failure. While most live kidney donors enjoy excellent health after kidney donation, recent research has revealed that kidney donation is linked with an increased risk of developing kidney failure.

Because of the gift of kidney donation, prior live organ donors receive priority on the kidney transplant waiting list. Peter Reese, MD MSCE, from the University of Pennsylvania’s Perelman School of Medicine,, Vishnu Potluri, MD, MPH, from Lankenau Medical Center, and their colleagues looked to see whether the current national kidney allocation policy was succeeding in its goal of minimizing waiting time to transplant for people who had once donated an organ. The researchers analyzed prior organ donors and matched non-donors who were wait-listed during the years 1996 to 2010.

“The research reveals that, fortunately, these donors did not wait a long time for their kidney transplants and received high quality kidneys,” said. Reese.

Prior organ donors had much shorter waiting time to receive a kidney transplant, and they received better quality kidneys compared with similar people on the waiting list who had not donated an organ.

“This study shows that the policy is working: prior organ donors get rapid access to high quality organs. After transplant, their survival is excellent compared with similar people who were not organ donors,” said Reese. He noted, however, that most prior organ donors needed dialysis before they received their transplant. Ideally, these prior donors would have received kidney transplants before they ever needed dialysis. ]Read more]




Living With PKD

From WIS TV, Columbia, South Carolina, By Meaghan Norman

For those with kidney disease, life goes on

In many cases, kidney disease can be prevented.

It's based largely on lifestyle: watching your blood pressure and your weight. But for some, it's an inherited disease.

"The mindset I had then as a 20 year old - I was invincible," said Brian McDonald.

McDonald has polycystic kidney disease, which means cysts grow in his kidneys.

He was diagnosed almost 10 years ago.

"After I was diagnosed in 2005, that's when it really shook me and made me realize I need to do something," McDonald said.

It started with taking better care of his body.

"Getting my blood pressure under control, that was number 1,” McDonald said. “And from there because of the kidney issues I was having I changed my diet. Watch my salt intake."

Getting your health on track helps prolong the life of the kidneys. Doctors also recommended dialysis.

"I'm there Monday, Wednesdays and Fridays for four hours," McDonald said.

Dialysis replaces your kidney function, removing toxins and excess fluid from the body.

There are two main options: Hemo-dialysis is done in a clinic several days a week and Peritoneal-dialysis is done at home every day.

It's a matter of which fits best into your life.

"Whether you decide to come into a clinic for treatment or do peritoneal, it's a lifestyle change not just for the patient but for the family also,” McDonald said.

When a patient begins dialysis for the first time they are given a social worker to help guide them through the new process.

"Every patient that I've had, I've been able to help them to get whatever benefits they need and coach them through that process," said social worker Amanda Bonner.

A process that includes helping patients afford dialysis and learning how to maintain a normal life.

"The diagnosis itself is heartbreaking,” McDonald said. “But it's better to know than not know. So once you know and find out, you can make your adjustments and keep moving."

And life goes on.

Sometimes it's hard to see that through a diagnosis or any traumatic life event but Brian McDonald made a point to stress, making the best of your situation. In his case, his disease was inherited but for many others, chronic kidney disease develops because of poor health choices.





From Green Bay Press Gazette, Green Bay, Wisconsin, by Alyssa Bloechi, Kewaunee County Star News

Lonnie Kinjerski benefit scheduled Dec. 6

When Lonnie Kinjerski was born, he was diagnosed with polycystic kidney disease (PKD). His parents, Voni and Paul, were told they would only have six to eight weeks with their newborn.

37 years later, the Kinjerski family is still enjoying the life of their son, who grew up to start a family with his wife, Amanda. They brought two children, Ian and Libby, into this world and have created a life full of love and happiness.

“We have a lot to be thankful for,” Voni Kinjerski said. “But now Lonnie’s kidneys have stopped working, and he will have to have a transplant. He is determined to keep going.”

According to the Mayo Clinic, PKD is an inherited disorder that causes the growth of clusters of cysts within the kidneys. Cysts are noncancerous sacs containing fluid that can vary in size, but can grow, eventually causing kidney failure and potentially other health complications.

Lonnie has been on dialysis since early spring and was put on the transplant list.

“A miracle happened,” Voni said. “A family friend, Kenny Barnes, learned he was a perfect match for Lonnie, and he will be donating one of his kidneys to help Lonnie.”

Barnes is not related to Kinjerski, and his being a non-biological match is incredibly rare.

“He is selflessly doing this so that Lonnie can continue to care for his family,” Voni said. “We are so thankful for what he is doing.”

A benefit to help fund the surgeries will be held in Lonnie’s honor from 1 p.m. to midnight Dec. 6 at Heritage Farm south of Kewaunee. Food and drinks will be served beginning at 1 p.m., and musical acts Ham’r Tyme and the Antique Rock Show Band will perform throughout the event. Children’s activities will be available, and Santa Claus will make a special appearance. A silent auction, 50/50 raffle and bucket raffle will also take place. Private donations can be made at any Baylake Bank location.

“The fact that this is happening is humbling and overwhelming,” Voni said.

Lonnie and his family live in Kewaunee, and he works at Kewaunee Fabrication, which has been very accommodating with Lonnie’s condition, Voni said.

“He has a strong will and work ethic, and he does not want to be a burden, so the fact that he is so loved is overwhelming to our family,” Voni said.

Lonnie enjoys music, playing keyboard, hunting, fishing and laughing with his family and friends.

This is the second benefit Lonnie has had, the first being in early November.

“This is bringing a lot of hope and happiness to our family,” Voni said. “This new kidney is truly a Thanksgiving blessing.”

The surgery will take place at Madison University Hospital.

Sunday, November 23, 2014

HALT - PKD Clinical Trial Results

PKD Research

From MedicalXpress

Two drugs are no more effective than one to treat common kidney disease

Two drugs are no more effective than 1 to treat common kidney disease


Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health (NIH). One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.

The results of the HALT-PKD Clinical Trials Network studies will be published online November 15 in two papers in the New England Journal of Medicine to coincide with presentation at the American Society of Nephrology annual meeting.

"Enlarged cysts in kidneys can lead to reduced kidney function and eventually kidney failure, where the only treatment is dialysis or transplantation," said study author Michael Flessner, M.D., Ph.D., a program director at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases, which funded the trial. "The HALT-PKD findings show that people with polycystic kidney disease do not need to take both of the drugs studied to slow their rate of kidney cyst growth and decline in kidney function."

The HALT-PKD trial enrolled volunteers to test whether a combination of commonly used FDA-approved drugs, lisinopril and telmisartan, could shrink kidney cysts and therefore slow progression of ADPKD, a genetic disorder characterized by growth of fluid-filled cysts in the kidneys. Within the trial, one study examined 558 people with early-stage ADPKD and relatively healthy kidneys. The other study treated 486 people with more advanced disease and decreased kidney function. In each study, half of participants were randomly assigned to receive lisinopril and telmisartan, while the other half received lisinopril plus a placebo. In both studies, adding the second drug did not change kidney function or rate of increase in kidney cyst size.

In the study of people with early ADPKD and healthy kidneys, researchers also tested if decreasing blood pressure below usual targets would slow progression of ADPKD and preserve kidney function. High blood pressure is a common and damaging effect of ADPKD. Half the participants were assigned to a standard blood pressure group (between 120-130 over 70-80), and half to a lower blood pressure group (between 95-110 over 60-75) but still within the normal range.

Participants in the lower blood pressure group received more rigorous treatment, taking more medication to maintain a lower blood pressure. The lower blood pressuregroup had a 14 percent decrease in kidney cyst size compared to those in the standard blood pressure group. However, kidney function - measured by estimated glomerular filtration rate (eGFR) - was about the same as the standard group at the end of the trial, yielding no clinical benefit. About 15 percent more of the people in the lower blood pressure group experienced lightheadedness and dizziness.

"The HALT-PKD studies were well performed and the largest of their kind," said Robert Star, M.D., director of the Division of Kidney, Urologic, and Hematologic Diseases within NIDDK. "More research is needed to better understand how polycystic kidney disease destroys kidney function over time, and what combination of medications can most safely and effectively prevent or undo the damage caused by this devastating condition."




From The Times of India, by Manash Pratim Gohain


Scientists at IIT-Bombay have developed a special membrane that promises to reduce the cost of dialysis by 50%, cut down time taken for the process by half and be safer for the patient. It could also spur development of portable or wearable dialysers.

Dialysis is the process of artificially removing waste and excess water from the blood in people suffering from chronic kidney failure. Due to the high cost of the procedure, around 90% of those who develop kidney failure in India die within months because of lack of treatment, according to an AIIMS study.

That could change in the coming years, with researchers at IIT-B's chemical engineering department hoping that their product will be available in the next three years. The hollow-fiber membrane developed by them has completed laboratory tests and awaits pre-clinical trials.

An Indian patent has been procured for the product. An indigenous and low-cost pilot plant for production of these membranes has also been functioning for the last two years.





From PKD Foundation

Active Studies – Not Yet Recruiting

For drugs and therapies to be developed for PKD, clinical studies must be conducted. Patients play a key role in the research and development process by volunteering to participate in clinical studies. From observational studies to clinical trials, you can help researchers unlock the secrets of PKD and find a treatment by participating in a study.

Minnesota
New Quantitative MRI Parameters in Assessing Kidneys of ADPKD (MRI Pilot)

International
Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD (GeneQuest)
The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease (PKD) Transplanted Recipients (EVERKYSTE)
Lanreotide in PKD Study (LIPS)

Not Listed
Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With ADPKD





Living With PKD

From Nephrology News, By Rebecca Zumoff

Frequent home dialysis provides survival advantage over in-center hemodialysis

Frequent home dialysis therapies may help prolong the lives of patients with kidney failure compared with hemodialysis treatments administered in medical centers, according to a study presented at ASN Kidney Week 2014.

Researchers led by Austin Stack, MD, MBBCh, FASN from the Graduate Entry Medical School, University of Limerick, in Ireland, analyzed national data to compare dialysis survival among 585,911 patients who started dialysis in the United States between 2005 and 2010.

Peritoneal dialysis and frequent home hemodialysis done at least six times a week offered the greatest patient survival compared to in-center hemodialysis, while home hemodialysis done only times three per week had the lowest survival rate, the authors concluded.

Among the major findings:
Patients who were treated with peritoneal dialysis were about 10% less likely to die during the study period than patients treated with standard 3-times per week in-center hemodialysis.
Patients receiving high frequency home hemodialysis delivered six times per week were 26% less likely to die during the study period than those receiving standard in-center hemodialysis.
Patients receiving less frequent home hemodialysis (four or five times per week) had mortality risks that were similar to those of patients receiving in-center hemodialysis.
Patients receiving home hemodialysis at a frequency of three times per week were 47% more likely to die than patients receiving in-center hemodialysis.

"We suggest that a treatment approach that adopts a peritoneal dialysis first or frequent home hemodialysis first strategy should be considered for all suitable patients who develop end stage kidney disease," said Dr. Stack. "Such an approach may offer superior survival, better quality of life, and be cost effective for national health care systems."

Study: "Survival Differences between Home Dialysis Therapies and In-center Haemodialysis: A National Cohort Study" (Abstract SA-PO957)

All the Kidney Week abstracts are available at https://www.asn-online.org/education/kidneyweek/archives.




From News-Medical.com

Majority of kidney dialysis patients not adequately prepared for emergency or natural disaster

But individualized education dramatically improves preparedness, Loyola study finds

Eighty percent of kidney dialysis patients surveyed were not adequately prepared in the event of an emergency or natural disaster that shut down their dialysis center.

But after receiving individualized education from a multidisciplinary team of doctors, nurses, dieticians and social workers, 78 percent of these patients had become adequately prepared, according to a Loyola University Medical Center study.

Anuradha Wadhwa, MD, and colleagues, reported findings during the ASN Kidney Week 2014 meeting.

Patients with kidney failure rely on dialysis treatments to survive. The treatments, typically three times a week for about four hours, remove wastes and extra fluids from the blood.

Researchers surveyed 124 patients at a Loyola outpatient dialysis center. During dialysis sessions, patients were asked whether they:

Believed they were prepared for an emergency.

Had an emergency plan they had discussed with a family member or dialysis unit.

Knew of a back-up dialysis facility.

Were familiar with an emergency diet that is key to survival in the event of a missed dialysis session. The diet includes limiting fluid intake and avoiding potassium-rich foods.


Patients who answered yes to all four questions were considered to be prepared. But while 60 percent of the patients thought they were prepared for an emergency, the survey found that only 20 percent were actually prepared. However, 95 percent of patients were interested in learning about preparedness. [Read more]

Sunday, November 16, 2014

PKD Goes BOP; PKD Research Award to UCSB; Fast Tracked Wearable Dialysis Device

PKD Fundraising

From PR.com

ArtistShare Launches the BOP Project

New Fan-Funded Album by Jeff Lorber and Chuck Loeb to Help Fund the Polycistic Kidney Disease (Pkd) Foundation.

New York, NY, November 12, 2014 --(PR.com)-- BOP is a one-of-a-kind traditional bebop album that brings together world-class musicians, conceived by Grammy nominated keyboardist/composer/producer, Jeff Lorber, and guitarist, Chuck Loeb. The concept was brought to life at the Berk’s Jazz Festival in Philadelphia, at which Loeb conducts the bebop jam sessions. They organized and co-produced the record together, and later recorded it at Lorber’s studio.

All proceeds from this fan-funded project will go to the Polycystic Kidney Disease (PKD) Foundation. Based in Kansas City, the PKD Foundation is fully committed to discovering treatments and a cure for the disease. Lorber is a kidney transplant recipient and many members of his family have suffered from PKD. This project is his way of spreading the word and giving back to the foundation that has done so much for him and his family.

Participants in the BOP project will get a look into the storyline of the project and how the album concept was created. Premium offers include credit listing on the record for supporting the PKD Foundation, being a special VIP guest at next year's Berks Jazz Festival, and meeting the musicians on BOP.

The BOP project’s homepage can be found online here:
http://www.artistshare.com/news/?pt=3704

www.ArtistShare.com

ArtistShare
Prawit Siriwat
(212) 501-8562



From InsideHalton, Halton, Ontario, Canada, By Justin Skinner


#giveaday encourages people to donate money to help children get well

Taylum Lamoureux

Taylum Lamoureux, reading with his mother Desiree, has been a SickKids patient virtually since he was born 19 months ago, having been diagnosed with polycystic kidney disease. He is one of the patients being featured as part of SickKids' new 'Better Tomorrows' fundraising campaign, which shows a different patient's story every day through Dec. 21.


With the giving season coming up, The Hospital for Sick Children (SickKids) is looking to put a human face – or 42 – on the hard work they do to keep children healthy.

The hospital’s 2014 brand campaign, Better Tomorrows, consists of a minimum of 42 commercials depicting real stories about real SickKids patients. Each 30-second spot will run on a different day until Dec. 21.

“These people are so courageous, and we asked if they would let us bring a camera in to film what is sometimes a really tough moment for them,” said David Estok of the SickKids Foundation. “The whole campaign is really trying to show authentic stories about what life is like for families at SickKids.”

Each commercial begins with the day’s date and an introduction to a SickKids patient or loved one. Estok said there could be even more than the 42 spots they have scheduled.

“We’re still shooting,” he said. “We’ll have 42 for sure, but there’s room for 45.”

There will also be additional spots that will air in movie theatres and online, making for a total of 50 different videos. Together, they represent the SickKids Foundation’s most ambitious digital project ever. [Read more]




PKD Research

From The Current, UCSB News, University of California, Santa Barbara, By Shelly Leachman
Unraveling a Biomedical Mystery

PKD kidney versus normal kidney

The top image reflects normal kidney function in a mouse; the bottom image comes from a mouse with PKD. The large circles outlined in red are the cysts caused by PKD.

Photo Credit: 

Jonathan Shillingford/Weimbs Lab
- See more at: http://www.news.ucsb.edu/2014/014504/unraveling-biomedical-mystery#sthash.nLf2QE0I.dpuf

With no cure, no approved treatment and no known means of slowing its progression, polycystic kidney disease is a biomedical cold case that affects more than 600,000 people in the U.S. alone — and some 12 million worldwide.
Hoping to crack that case with science, UC Santa Barbara biologist Thomas Weimbs is working to develop a new therapeutic approach by targeting the mechanism that causes the cysts to grow. A new gift to his lab is providing a big boost to that effort.
After a competitive selection process, the Lillian Goldman Charitable Trust of New York has awarded $600,000 to Weimbs to support his team’s continued work on autosomal-dominant polycystic kidney disease (ADPKD or PKD). Weimbs is one of the world’s top experts in the disease, a potentially fatal genetic condition that leads to renal failure and causes major cardiovascular complications.
“We are thrilled and grateful to have received funding from the Lillian Goldman Charitable Trust, which will greatly help to accelerate the progress of our research,” said Weimbs, a professor of molecular, cellular and developmental biology. “My lab is very focused on understanding the mechanisms that are most critical for the development of the thousands of cysts that eventually destroy both kidneys in PKD patients. We are driven by the motivation to develop a feasible therapy to at least slow disease progression and are working on several highly promising approaches in parallel. Philanthropic, targeted funding such as this can make a huge difference in speeding up the progress of research.”  [Read more]



From io9.com, by Annalee Newitz


This Medical Device Is a Major Gamechanger for Kidney Patients


This device could improve the lives of tens of thousands of people who visit kidney dialysis centers. Using this 10-pound, miniature portable dialysis machine, they can cleanse and monitor their blood constantly, with minimal effort. The FDA has just put the device in its new "fasttrack program."

David Russell Schilling highlights the new technology over on Industry Tap, noting that it won't be in the human testing phase until 2017. So we've still got a few years to wait before this is available on the market. But once that happens, medical device designers expect that portable dialysis devices will get smaller and smaller until ultimately they're implantable.

So this kidney dialysis device is basically the first step toward artificial kidneys, which might one day be transplanted into patients with organ failure. For now, though, this device will give kidney patients many new freedoms that are difficult when you depend on being near dialysis centers. [Read more]




Living With PKD, Eating Right During the Holidays, Control BP

From NewsWire.ca, PKD Foundation of Canada

Interview and Live Cooking Opp: Renal dietitian helps you stay on track during the holidays

Eating healthy over the holidays can be overwhelming for many, with family dinners and work parties derailing even the best of intentions. Store-bought goods and some of our favourite recipes can be very heavy in sodium, and for the estimated three million Canadians1 suffering from chronic kidney disease, it's even more difficult to prepare and adhere to a balanced, kidney-conscious diet.

Kelly Welsh, registered dietician and author of the acclaimed cookbook, Brilliant Eats, Simple and Delicious Recipes for Anyone Who Wants to Be KidneyWise, has been living with polycystic kidney disease (PKD) for 17 years. After spending years trying to find kidney-friendly recipes, she decided to publish her own cookbook to help others who were also looking for answers.

Brilliant Eats is full of delicious, original, recipes and includes information on the impact of a renal-friendly diet for those who are looking to make a change.

Kelly will be in Toronto for the first-ever Canadian Polycystic Kidney Disease Symposium, hosted by the PKD Foundation of Canada and is available for a live cooking demonstration on Thursday, November 20th and Friday, November 21st to showcase some of her favourite recipes for the holidays. She can also speak to the importance of a kidney-friendly diet for all Canadians and how to overcome the holiday challenges, including not giving in to boxed stuffing. [Read more]




From Renal And Urology News, by Jody A. Charnow, Editor


Rigorous blood pressure control can reduce the rate of increase in total kidney volume (TKV) in younghypertensive patients with autosomal dominant polycystic kidney disease (ADPKD) and relatively preserved kidney function, a researcher reported at the 2014 Kidney Week meeting.

“Low blood pressure treatment in healthy young hypertensive ADPKD patients with renin-angiotensin-system blockade is well tolerated and safe and results in a 14.2% slower rate of total kidney volume growth over 5 years, is associated with reduced left ventricular mass index, urinary albumin excretion, and renal vascular resistance,” said Arlene B. Chapman, MD, of Emory University in Atlanta.

Dr. Chapman presented the findings of a placebo-controlled, double-blind study of 558 hypertensive ADPKD patients aged 15–49 years who had an estimated glomerular filtration rate (eGFR) above 60 mL/min/1.73 m2.

She and her colleagues compared the effect of the ACE inhibitor lisinopril alone or in combination with the angiotensin receptor blocker (ARB) telmisartan and the effect of low versus standard blood pressure (BP) on the annual percent change in TKV. The researchers defined low BP as 95–110/60–75 mm Hg and standard BP as 120–130/70–80 mm Hg.

Results showed that subjects in the low BP group experienced a 14.2% slower annual increase in TKV than the standard BP group (5.6% vs. 6.6% per year), but did not differ significantly between the patients receiving lisinopril alone or in combination with telmisartan. [Read more]




Gift of Life

From WALB, NBC Affiliate Albany, Georgia, By Shannon Wiggins

Walgreens employee raises money for kidney transplant

Workers at Walgreens are helping out their District Manager whose in need of a kidney transplant. Today supporters sold hamburgers and hot dogs at the Walgreens on Slappey.

Workers at Walgreens and Kauffman Tires are firing up the grill to help out Keith Brendel who's in need of a kidney transplant.

"So 18 months ago, I was diagnosed with Polycystic Kidney Disease which affects the use of the kidney,” said Keith Brandel.

Brendel has been with Walgreens for more than 20 years and was surprised to discover his diagnosis.

"My initial reaction was that I didn't understand it,” said Brendel. “ I didn't know what it was."

Since then, his co-workers have put on several fundraisers.

" I know right here at our store on Slappey, we do jeans every Friday, we pay for that to help raise money and we thought about this, and we also been doing bake sales as well,” said Erica Richardson, Co-worker.

His Co-workers say Brendel does a lot for the community.

"He does a lot for all of our stores in our community,” said Ashley Morey, Co-worker. “So when we have a chance to give back we like to help him."

Brendel is working with doctors at Shands Hospital in Florida, and is on a waiting list.

"I was just put on the national list to get a kidney transplant and there's a possibility we have somebody that we know locally that may be taking care of donating a kidney, which is just amazing in itself,” said Brendel.

He says he's thankful for the support he's receiving around South Georgia.

"Being an employee of Walgreens, the family that we have here is amazing,” said Brendel. “More and more it's not just about the name on the wall. It's about the families that are created and the support that they give."

Brendel needs $22,000 for the transplant. He hopes to have the surgery before the end of the year. You can help Keith Brendel by making donations at any Albany Walgreens.




From The Gadsden Times, Gadsden, Alabama, By Lisa Rogers Savage

Give and Receive: Woman donates kidney through program so her brother can get a match



When Nancy Couch received the news last year that her brother had end-stage renal failure, she knew he would die without a kidney transplant. She knew right away she wanted to donate one of hers.

The decision, she says, was easy. The process wasn’t so simple.

After numerous tests, Nancy, 47, found out she was not a match for her 50-year-old brother, Bill Couch, who has polycystic kidney disease. So she began to explore the Kidney Paired Donation Program — a program that allows her to donate her kidney and, in turn, someone donates a kidney to her brother.

Her brother began dialysis Dec. 4. Statistics show a person’s life expectancy at that point is five years, but Bill’s prognosis was grimmer, based on the progression of his disease.

The waiting list for a deceased donor is more than three years; it’s even longer for a living donor.

Nancy and her brother grew up in Marietta, Ga., but she ended up in Gadsden several years ago, working at Corporate Pharmacy.

Their mother also has polycystic kidney disease, a hereditary disease that never skips a generation. It was inevitable that either she or her brother or both would have it. [Read more]





Kidney Week

From MedPage Today, By Kristina Fiore


PHILADELPHIA -- Nephrologists involved in the care of Ebola patients at Emory University will present their clinical exerience during a special session at this year's Kidney Week meeting.

Harold Franch, MD, will present a case report, and Michael Connor, MD, will discuss safety during the "Ebola and Dialysis" symposium at 10:30 am Friday in Hall D.

Franch and Connor have previously discussed some aspects of the role of dialysis in Ebola treatment in a Q&A with MedPage Today.

There will also be discussion of new guidelines for Ebola in dialysis developed jointly by the American Society of Nephrology and the CDC, presented by lead author Sarah Faubel, MD, of the University of Colorado Denver.

Helmut Geiger, MD, chief of nephrology of Frankfurt University Hospital in Germany, will present his center's experience treating an Ebola patient with the Hemopurifier -- a filtration device that manufacturer Aethlon Medical says can remove virus particles from the blood...

Late-Breakers

During a late-breaking trials oral session on Saturday morning, two groups will present findings from the HALT PKD trial, an NIDDK-funded trial looking at preventing kidney growth in polycystic kidney disease.

Another session will present more data from the ADVANCE-ON trial, focusing on the long-term effects of intensive glucose control in diabetic patients on end-stage kidney disease.

Researchers will also present efficacy and safety data on anti-TGF-beta1 therapy in diabetic nephropathy, a condition for which there have been few treatment options.

Kidney Stem Cells

Susan Quaggin, MD, of Northwestern University, head of this year's scientific program committee, said the meeting will focus on several new frontiers in renal research, particularly the advances in building a working kidney, "from how we can take a biopsy of a skin cell, reprogram it, and eventually turn it into a kidney, to help reduce the organ shortage while avoiding immunosuppression issues."

"There have been a lot of advances with other tissues, but the kidney is a complex organ and it requires a lot more work," Quaggin said.

A two-day preliminary program in conjunction with the National Institutes of Health will provide the most in-depth look at this process, but Quaggin said there will also be a symposium on stem cells in kidney care during the main meeting.

Sunday, November 9, 2014

Launch Pumpkins for PKD, PKD Foundation on Pinterest; Kidney Week Conference

PKD Fundraising & Awareness

From PSUCollegio, by Haley Riebel

Chunkin’ Punkins


At the end of every Halloween season there seems to be more than enough candy around, but the once intricately carved jack-o-lanterns start to rot and it’s time for them to go. For those who forgot to Pinterest a way to make their pumpkins last longer, the rotting ball of moldy mush usually gets thrown out. But Sara Pope had a different idea.

Sara Pope, senior in social work, launches a pumpkin at the PKD Pumpkin Chunkin fundraiser on Sunday, Nov. 2.

PKD Pumpkin Chunkin

Pope, senior in social work, decided to organize “Punkin’ Chunkin,’” an a fundraiser in which she raised awareness of polycystic fidney disease while allowing people to dispose of unwanted Halloween leftovers in a more splattering way.

About 20 residents and students joined in Pittsburg’s first Punkin’ Chunkin’ on Sunday, Nov. 2. where the top chuck of the day was recorded at 24 feet.

“There were not as many people as we wanted…but she (Pope) got a lot of awareness out,” said Valerie Ashcraft, senior in social work, who brought her children to participate in the event. Ashcraft’s son received third place with a launch of 17 feet, 4 inches.

Punkin’ Chunkin’ Pittsburg began as a project for Pope’s field study. The state of Delaware hosts a world championship Punkin’ Chunkin’ each year and Pope chose to bring the event to Pittsburg to discard of old jack-o-lanterns and raise money for PKD research, a disease that hits closer to home for Pope as her husband and three of her siblings have all been diagnosed with it.

“I’ve always wanted to go to Delaware’s Punkin’ Chunkin’,” Pope said. “I’ve not gotten the chance so I made the best of my circumstances. As a social work student we are given opportunities to interact in environments we may encounter. This was my way of bringing an experience to SEK.”
PKD affects one in every 500 people, with most cases becoming present during childhood. Cases tend to gradually become worse when an individual with the disease reaches adulthood, as it spreads from the kidneys to other organs such as the liver. Children with one parent suffering from the disease have a 50 percent chance of getting it themselves.

Pope was not alone in her fight for awareness.
The catapult used during Punkin’ Chunkin was brought by a resident and other organizations. Including Home Depot, The Medical Lodge, Fuzzy’s Taco Shop, Chatter’s, Sweet Designs Cakery, TJ Belcher Insurance, Jock’s Nitch, and Mall Deli teamed up with Pope to organize the event and make supply donations.

Pope set a goal of raising $500 during the event, $90 of which was met through entry fees and concessions. [Read More]



From Pinterest


If he can give, so can you. #GivingTuesday #PKD www.pkdcure.org/giving-tuesday




PKD Research

From MedScape, by Daniel M. Keller, PhD

Kidney Week Takes New Paths in Science and Medicine

PHILADELPHIA — When an all-time high of about 13,000 kidney professionals converge on Philadelphia for Kidney Week 2014, their biggest problem will be how to decide which lectures and sessions to attend. The meeting, running from November 11 to 16, will be rich with state-of-the-art basic and clinical science lectures, clinical nephrology conferences, high-impact trial results, and late-breaking presentations.

At least nine important clinical trials will be presented in an oral abstract session on Saturday. Two concern the HALT Progression of Polycystic Kidney Disease trial, which is testing whether interruption of the renin-angiotensin-aldosterone system can slow the loss of renal function in early-stage and moderately advanced disease. A presentation on the ADVANCE-ON follow-on trial will report on the long-term benefits of intensive glucose control for end-stage kidney disease.

The ACT-AKI phase 2 trial should begin to shed light on the potential for stem cell therapy. The trial tests mesenchymal stem cells as a potential treatment for acute kidney injury in cardiac surgery patients.

In addition to these oral presentations and hundreds of posters, more than a dozen late-breaking posters will give attendees a chance to chat with researchers about their work.

The theme of this year's meeting is Building New Paths to Kidney Health, because "nephrology is now almost facing a mid-life crisis" in light of the changing healthcare landscape and rapidly advancing science, said Sharon Moe, MD, from Indiana University School of Medicine in Indianapolis, who is president of the American Society of Nephrology (ASN).

The prescription for moving forward is to take new roads in new directions, she told Medscape Medical News. One of those directions is to think in terms of health, rather than just treating disease.

Another is to bring society members up to speed on the latest science that will soon affect the practice of nephrology. A precourse called From Stem Cells to Function will explore stem cell transplantation to repair or even rebuild a kidney. There will be "lecturers from all over the world who are experts in this area, not necessarily just in kidney," Dr Moe said. Many of them will stay on to give more talks during the main meeting.

Pioneering Work

The 2-day stem cell course will "really cover every aspect, from what we know about stem cells in the kidney to how we can reprogram a skin cell to make a kidney in a patient," said Susan Quaggin, MD, from Northwestern University in Chicago, who is the ASN program committee chair. These issues have long-term implications for the problem of shortages of organs for transplantation and the amount of immunosuppression needed.




Living With PKD

From Cyprus Mail, By Bejay Browne

Saving lives in Paphos


THE PAPHOS hospital renal unit is finding it difficult to keep up with the demand for life-saving dialysis as new patients are registering virtually every month, it says.

The unit is to receive a new €25,000 state-of-the-art dialysis machine next week, the money for which was raised by the Paphos-based Cyprus Kidney Association (ex-pats) with a substantial donation of €7,000 from the Dashin Foundation.

At the moment the renal unit at the hospital has 11 dialysis machines in use, and one available for spares. All 11 machines are working to capacity, and are outdated.

The kidney association is currently in the process of raising money for a second state-of-the-art machine by the end of the year. Currently they have come up with around €9,000 towards the cost. Without dialysis kidney patients would invariably die within one week.

Dr Lakis Yioukkas who runs the Paphos renal unit, said the new machine was vital and it also gives a special type of dialysis “which is better for the patient as their blood will be clearer,” he said.

Yioukkas said close to 6,000 dialysis treatments were carried out at the facility last year and new machines were urgently needed.

“I currently have 53 patients needing dialysis. This has increased considerably from a few years ago where numbers were around 20,” he said.

The doctor said the main cause of renal failure was diabetes and this was now increasing dramatically on a global scale due to the lifestyle many people adopt.

“In Paphos, the second main cause is also hereditary,” said Yioukkas.

“Latest statistics show that at least 10 per cent of the population of Paphos suffers with some sort of kidney problems. If you say that the population of the district is 100,000; that’s 10,000 kidney patients,” he added.

According to the kidney association, the specific genetic disorder in Paphos could be traced back to villages in the Marathasa region about 400 years ago.

This genetic predisposition would cause 40 per cent of male patients with kidney disorder to end up on dialysis before they were 70.
Yioukkas said new patients presenting were of all ages, even as young as 40.

He said there were five stages of kidney failure and it was only at Stage 5 that dialysis or transplants were needed. Dialysis involves five hour stints three days a week.

“In the last 20 years we have also carried out 80 kidney transplants in Paphos and the number is increasing,” said the doctor. “People need to change their lifestyles, their diet and exercise more frequently.”

In general, according to studies, one in ten Cypriots, or 80,000 people will suffer from a kidney disorder in the foreseeable future, and Cypriots suffer nearly three times the European average for serious kidney complaints.

Graham Brown, 64, suffers from a hereditary condition-polycystic kidney disease- and he recently took over as the chairman of the Cyprus Kidney Association (ex-pats), which was set up in 2000 to raise funds for the renal unit.

He spoke to the Cyprus Mail while hooked up to a dialysis machine at the hospital. Following the removal of one of his kidneys, he started dialysis treatment in November last year.

Brown said that the latest machine is the most modern one on the market, complete with a touch screen. It is smaller and more reliable than machines currently in use at the unit, which sees the technician constantly having to repair one or other of them, he said.

“A technician is flying over from the manufacturers in Germany for four days to instruct all the nurses within the unit on the use of this ultra modern state of the art piece of equipment. The nurses are all really pleased and we are hoping that it makes their job easier.” [Read more]


Sunday, November 2, 2014

Kidney Transplant News

Improving Transplant Procedures

From Daily Mail Online, London, United Kingdom

Saved from life on dialysis... by the UK's first ever keyhole kidney transplant operation: Former soldier given sister's organ in pioneering procedure


Brian Blanchard faced a lifetime of dialysis after suffering from kidney failure
But a pioneering keyhole kidney transplant operation has changed his life
Surgeons removed his sister's kidney through groin rather than abdomen
Kidney was then inserted through a small incision in Brian's abdomen
Previously the procedure would have needed a 10-inch opening to be cut

A former soldier has become the first person in Britain to undergo a pioneering keyhole kidney transplant.

Brian Blanchard, 51, who had been suffering from kidney failure, was facing a lifetime of dialysis treatment until surgeons carried out operations last month that featured two breakthroughs in keyhole surgery techniques.

In the first, the organ – donated by Brian’s sister Pam Morphett – was removed through her groin rather than her abdomen, leaving her with a far less visible scar.

In the second, the kidney was inserted through an incision in Brian’s abdomen measuring just two and a half inches. Previously, a ten-inch opening would have been needed for the operation.

Surgeons say the new techniques pave the way for safer transplant operations, and to patients recovering more quickly.

Brian, from New Brighton, Merseyside, who now runs an engineering company owner, says he is proud to be the UK’s first patient for this procedure.

‘The surgeon told me it would mean less pain and a quicker recovery,’ he says.

‘To be honest, I was just delighted that my sister turned out to be a tissue and blood type match so was able to help. My scar is already barely visible – I’m amazed how they managed to insert the kidney through such a small hole. It’s only three weeks since the operation, and I’m already out walking the dog.’ 


 [Read more]



From Business Standard, India

Blood group mismatched kidney transplant performed

A city hospital claimed to have performed a rare and successful kidney transplant on a 28-year old youth, who had no no blood group matched donor in his family.

The man was struggling on dialysis for the last two years and had registered for a cadaver or deceased donor for kidney transplantation. However, due to long waiting list, he was unlikely to get a cadaver donor in the next three years, G Bhakthavathsalam, Chairman, K G Hospital, said in a release today.

After seven days of specialised desensitisation treatment, he had mismatched kidney transplant from his AB positive mother and made a rapid recovery and was discharged, along with his donor mother from the hospital, in just one week after transplant surgery, which was performed a fortnight ago.

The doctors have done such a complex procedure in almost at the same cost as a regular kidney transplant and the patient was discharged in a record time, he said.

The first ABO mismatched kidney transplant in the country was done in April 2009 in Christian Medical College, Vellore.

Approximately, 30 per cent of patients who want a kidney transplant do not have a blood group matched donor. Without transplant, patients end up getting long term dialysis, which is costly (Rs.Three lakhs per annum), affects their quality of life (depend on others and difficult to continue work) and compromise their long term survival (average survival 3-6 years), he said.

Since the average waiting time for cadaver transplant is increasing and is at present more than 3 to 4 years, ABO mismatched transplant is a boon for dialysis dependent patients.




Kidney Blackmarket

From MedicalXpress.com, by Preeti Jha

Cambodia-Thai kidney trafficking sparks fears of new organ market

The seven-inch scar runs diagonally across the left flank of his skinny torso, a glaring reminder of an operation he hoped would save his family from debt but instead plunged him into shame.

Chhay, 18, sold his kidney for $3,000 in an illicit deal that saw him whisked from a rickety one-room house on the outskirts of the Cambodian capital Phnom Penh to a gleaming hospital in the medical tourism hub of neighbouring Thailand.

His shadowy journey, which went unnoticed by authorities two years ago, has instigated Cambodia's first-ever cases of organ trafficking and the arrests of two alleged brokers.

It has also raised fears that other victims hide beneath the radar.

At the corrugated iron shack he shares with nine relatives, Chhay says a neighbour persuaded him and a pair of brothers—all from the marginalised Cham Muslim minority—to sell their kidneys to rich Cambodians on dialysis.

"She said you are poor, you don't have money, if you sell your kidney you will be able to pay off your debts," the teenager told AFP, requesting his real name be withheld.

Identical stories have long been common in the slums of India and Nepal, better-known hotspots for traffickers. Up to 10,000, or 10 percent, of the organs transplanted globally each year are trafficked, according to the latest World Health Organization estimate.

But on discovering the broker earned $10,000 for each kidney they sacrificed, the donors filed complaints, alerting police in June to a potential new organ trade route.

"Kidney trafficking is not like other crimes... If the victims don't speak up, we will never know," said Phnom Penh's deputy police chief Prum Sonthor.

In July his force charged Yem Azisah, 29—believed to be a cousin of the sibling donors—and her step-father, known as Phalla, 40, with human trafficking.

The pair are being detained and await trial.

First case

Trafficking is a widespread problem in impoverished Cambodia and police routinely investigate cases linked to the sex trade, forced marriage or slavery—but this was the first related to organs.

"This is easy money that earns a lot of income, so we are worried," said Prum, adding there were at least two other Cambodian donors taken to Thailand who had not filed complaints.


The complicity of donors, whether compelled by poverty or coerced by unscrupulous brokers, makes it an under-reported crime which is difficult to expose.

In August media reports emerged about new alleged organ trafficking cases at a military hospital in Phnom Penh.

Prum, who investigated the case, said it was a training exercise between Chinese and Cambodian doctors, using voluntary Vietnamese donors and patients.

But he was unable to rule out whether money changed hands. [Read more]




Gift of Life

From Vinton Newspapers, Vinton, Iowa, by Jim Morrison

The cost of getting a great gift

The alarm needlessly rang at 4:30, just as it did every Monday, Wednesday and Friday. Already lying awake, I rolled out of bed, hit the shower and fixed breakfast.

The daily routine on those days called for arrival at the Mercy Dialysis Center at Virginia Gay Hospital by 10 minutes to six. I’d been on dialysis for kidney disease since 2011 so it had become pretty routine.

As I drove across town, my cell phone rang in my pocket but I let it ring. Several joggers and walkers fill the streets about that time of morning and I didn’t want to be distracted.

As I pulled into my parking spot the phone rang again. Pulling it out of my pocket, I noticed it was the same phone number that had tried to reach me a few minutes earlier.

“Hello.”

“I’m really glad to get a hold of you. This is Amanda with the University of Iowa Transplant Center. We have an awesome kidney for you.”

“What?”

“We have an awesome match for a kidney for you. We need you to get down here as soon as possible.”

My world stopped.

We continued talking as I walked into the hospital to let Hope and Emily know my dialysis chair would be empty that day. Turning the corner into the treatment center, I started to speak and then broke into tears.

Hope and Emily looked with great concern and I could only move my mouth silently between the tears.

“Transplant.”

Ending the phone call, I got through telling them the details, headed out and almost ran over a jogger as I drove over to the office – a perfect example of why the staff in Iowa City didn’t want me driving myself to the hospital. As I posted a message on Facebook, the transplant center called again. They had decided they wanted me to get a couple of hours of dialysis before leaving for Iowa City.

As I drove back, I phoned Becky with Leaping Rescues to let her know the developments and to pick me up at home in a couple of hours. Hope got me hooked up with those big dialysis needles and surprisingly I slept for a while. Emily observed they were losing a patient, but it was for the right reason.

The wait for a kidney had started in May of 2011 after my diagnosis of kidney disease. The ailment was caused by uncontrolled high blood pressure and a couple of severe bouts of diarrhea. Many hours of dialysis had finally led to this phone call.  [Read more]